Formation and Persistence of Sterigmatocystin--DNA Adducts in Rat Liver Determined Via 32P-postlabeling Analysis
Overview
Authors
Affiliations
A 32P-postlabeling method has been employed to detect the in vitro and in vivo modification of DNA by the mycotoxin sterigmatocystin (ST). ST-modified DNA was initially incubated under buffered alkaline conditions to convert unstable ST-N7-guanine moieties to stable, putative ST-formamidopyrimidine derivatives. DNA was subsequently digested with micrococcal nuclease and spleen phosphodiesterase, and the resulting ST-modified nucleotides, purified by reverse-phase thin-layer chromatography (TLC), were labeled at the 5' position via incubation with [gamma-32P]ATP and T4 polynucleotide kinase. 32P-labeled ST-nucleotides were separated by reverse-phase and anion-exchange TLC. Cerenkov quantitation of excised TLC fractions indicated that ST-DNA moieties could be detected with a sensitivity of 1 ST adduct in 3-5 X 10(7) nucleotides. Initial enzymatic digestion of ST-modified DNA was found to yield ST-modified di- and trinucleotides which, upon 32P-labeling followed by incubation with nuclease P1, liberated unmodified 5'-terminal nucleotides suggesting that ST-formamidopyrimidine-modified DNA was a poor substrate for micrococcal nuclease and spleen phosphodiesterase. Dose-dependent ST-DNA adduct formation was detected in the liver of male Fischer 344 rats over a 27-fold range of ST administered (0.33-9 mg/kg). In addition, ST-DNA adducts, formed in rats given a 9 mg/kg dose, were found to persist up to 105 days after treatment at a level of 0.5% of the 2-h value. Loss of these adducts from liver DNA was observed to exhibit a triphasic profile: rapid loss during the first 24 h (t 1/2 = 12 h) followed by a slower decline from 1 to 14 days post dosing (t 1/2 = 7 days) and an extremely slow decline from days 14 to 105 post treatment (t 1/2 = 109 days). This experimental approach to the study of mycotoxin-DNA interactions permits the quantitative description of DNA modification in ST-treated animals. Further refinement of this approach may be useful in defining the precise relationship between ST exposure and tumorigenesis in ST-exposed human populations.
Sterigmatocystin in foodstuffs and feed: aspects to consider.
Viegas C, Nurme J, Pieckova E, Viegas S Mycology. 2020; 11(2):91-104.
PMID: 32923018 PMC: 7448898. DOI: 10.1080/21501203.2018.1492980.
Dubravka R, Daniela J, Andrea H, Domagoj K, Nevenka K, Lada R Mycotoxin Res. 2019; 36(2):181-191.
PMID: 31836962 DOI: 10.1007/s12550-019-00382-8.
Jaksic D, Segvic Klaric M, Crnolatac I, Sijakovic Vujicic N, Smrecki V, Gorecki M Mar Drugs. 2019; 17(11).
PMID: 31698712 PMC: 6891739. DOI: 10.3390/md17110629.
The potential usefulness of biological markers in risk assessment.
Perera F Environ Health Perspect. 1987; 76:141-5.
PMID: 3447891 PMC: 1474459. DOI: 10.1289/ehp.8776141.
Gupta R Cell Biol Toxicol. 1988; 4(4):467-74.
PMID: 3228714 DOI: 10.1007/BF00117774.